Samsung BioLogics announced that it has been licensed by the US FDA to manufacture a monoclonal antibody Drug Product at...
Myongji Hospital and leading US based telehealth firm InTouch Health have partnered to test out a telehealth system in K...
GE Healthcare has finished installing its 400th cyclotron at Korea Institute of Radiological Medical Sciences (KIRAMS), ...
Peptron Inc. a Korean-based public pharmaceutical company that focuses on peptide engineering and developing sustained-r...
According to PRASM, the biometric data of individuals who use hospitals, medical and healthcare services are currently b...
India and South Korea have signed five MoUs in the field of Science & Technology. Union Minister for Science & T...
Singapore – Bayer announced results from the Asian analysis of OPTIMIS, the first prospective real-world stud...
Inovio Pharmaceuticals, today announced positive Phase 1 results of its collaborative vaccine study with INO-4700 ...
Singapore – Scientists and clinicians from Singapore institutes are collaborating with C&C Research ...
Singapore – Esco Aster, a leading independent contract development and manufacturing organization with its patent ...
Merck, the German multinational company, is aiming to expand its presence in Korea’s life sciences and health care...
Mundipharma has announced the extension of its strategic partnership with Kolon Life Science to market Invossa-K in Saud...
A team of scientists in South Korea has developed a sensor that detects bad breath. The sensor detects tiny amounts of h...
PATH has announced a new partnership with South Korean company SD BIOSENSOR to support the development and availability ...
Samsung Electronics Co. said Tuesday it has developed a new ultrasound image processing engine with its medical instrume...
Mundipharma has announced a licensing agreement with Korean biomedical firm, Genewel , to market and distribute its GUAR...
MediWound Ltd., a fully-integrated Israel based biopharmaceutical company bringing innovative therapies to address unmet...
Eisai Korea, the Korean unit of the Japanese pharmaceutical company, has chosen Chong Kun Dang as a partner firm to sell...
